HOME >> BIOLOGY >> NEWS
Hearts of male and female rainbow trout are different

Ventricle rings were processed, sectioned and stained. Light microscopy was used to capture images of ventricle layers and analyzed for layer cross-sectional areas. Lactate concentration and net lactate release from cardiac tissue was also examined.

Results

The researchers found:

  • ventricle strips from males and females had similar rates of oxygen consumption and lactate release under resting conditions;

  • the inhibition of oxidative metabolism with NaCN lowered cardiac performance dramatically, and elevated resting tension and lactate release in both males and females;

  • under stimulated conditions with DCA vs. controls, female ventricle strips selectively demonstrated better performance and reduced lactate release;

  • force production during reoxygenation -- after a hypoxic insult -- significantly improved in males receiving DCA, but not females;

  • male ventricle tissue had 2.5-fold higher citrate concentrations than females; and;

  • males had a proportionately larger epicardium to endocardium ratio compared with females with similar size hearts.

Summary and Conclusions

This study expands upon previous findings that sex differences in cardiac performance and metabolism exist in fish in general, and have now been found to occur in rainbow trout in particular. Moreover, the differences are only realized during working conditions and involve stimulation or inhibition of the glycolytic pathway and carbohydrate oxidation. Ultimately, sex differences in cardiac energy metabolism and function may help define habitat suitability, swimming capabilities and health status of wild and hatchery-reared rainbow trout, and human heart disease, sex-specific treatment.


'"/>

Contact: Donna Krupa
DKrupa@the-APS.org
301-634-7209
American Physiological Society
30-Apr-2007


Page: 1 2 3

Related biology news :

1. Hearts or tails?
2. Cardio exercise benefits in male vs. female hearts
3. The female advantage in kidney disease does not extend to diabetic women
4. Disabling a sensory organ prompts female mice to act like male mice
5. A sensory organ, not the brain, differentiates male and female behavior in some mammals
6. MGH researchers confirm that bone marrow restores fertility in female mice
7. Male or female factor infertility -- men suffer just the same
8. CU study reveals why starling females cheat
9. Philandering female felines forgo fidelity
10. Update on census of wrlds most endangered cat -- female Amur leopard found dead
11. The sturdier sex? -- Study by Pittsburgh scientists finds female stem cells work better

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hearts male and female rainbow trout are different

(Date:12/10/2014)... , December 9, 2014 ... BCARD Platform   ... meeting scheduling solutions for business-to-business (B2B) events, today ... leader in mobile near-field communication (NFC), Bluetooth low ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will ...
(Date:12/3/2014)... , Dec. 2, 2014 As part of ... Inception Technologies is pleased to announce the release of ... customers to collect the workforce data that they need. ... have been left by existing readers. Many such devices ... connectivity and modern technology. Older models force users to ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Inception Technologies to Release New Biometric Reader 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
(Date:12/19/2014)... (PRWEB) December 18, 2014 LayerBio is ... ophthalmology and wound care. The National Eye Institute (NEI) ... LayerBio a Phase I SBIR grant to develop a ... are the most common cause of vision loss in ... blindness worldwide. According to Dr. Ken Mandell, LayerBio’s Founder ...
(Date:12/19/2014)... 2014 The empty capsules market ... ageing population and technological innovations in the empty ... are catalysing the growth of the empty capsules ... , Scope of Report , The report ... new entrants/smaller firms to gauge the pulse of ...
(Date:12/19/2014)... Dec. 18, 2014 Relmada Therapeutics, Inc. (OTCQB: ... treatment of chronic pain, announced the results of its ... "This was a transformational year in Relmada,s history and ... our company," said Sergio Traversa , chief executive ... executed on key financial, human resource and clinical development ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Ipsen ... IPN; ADR: IPSEY), today announced that ... to as Somatuline®) was approved by the U.S. ... of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients ... or metastatic disease to improve progression-free survival (PFS). ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
Cached News: